- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01127932
Developing an Intervention to Address Suicide Risk During Substance Use Disorder
May 11, 2015 updated by: Mark A. Ilgen, University of Michigan
This is a 2-year study designed to: (1) adapt and refine an existing cognitive-behavioral treatment (CBT) intervention to decrease suicidal thoughts and behaviors for use in Substance Use Disorder (SUD) treatment settings, and (2) conduct a pilot randomized controlled trial with 50 patients in treatment for SUDs comparing the CBT intervention to an enhanced control condition.
Through this pilot randomized controlled trial, the investigators hope to not only obtain information about the feasibility of implementing these procedures in residential SUD treatment, but to also determine whether this intervention decreases the level of suicidal ideation, suicide attempts, hopelessness, and frequency of substance use relative to the control condition.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Existing research indicates that problematic alcohol and drug use are closely linked to both fatal and non-fatal suicide attempts.
Given the strong association between substance use and suicide, an episode of substance use disorder (SUD) treatment provides a unique opportunity to decrease the likelihood of suicidal behaviors.
However, there are no data on the effectiveness of specific interventions designed to decrease suicidal thoughts and behaviors during an episode of SUD treatment in individuals at high risk for suicide.
Patients for this trial will be screened at the SUD treatment site for a combination of a past suicide attempt and current suicidal ideation and will be randomized to CBT or control conditions.
All participants in the pilot randomized controlled trial will be assessed at baseline, at the end of treatment, and at a 3-month follow-up.
From a public health perspective, SUD treatment programs contain large numbers of patients at high risk for future suicidal behaviors and therefore have the potential to play a central role in our nation's efforts to decrease suicide.
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Waterford, Michigan, United States, 48327
- Community Programs, INC.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must be over 18 years of age
- Report a past lifetime suicide attempt
- Report current suicidal ideation
- Resided in treatment for less than 4 weeks
- In treatment for less than 6 months
Exclusion Criteria:
- Mental incompetence (e.g. unable to provide informed consent)
- Diagnosis of schizophrenia or currently psychotic
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CBT for suicide
|
The therapeutic intervention group is designed to provide beneficial coping strategies that are helpful in dealing with both substance use and suicidal thoughts.
|
|
Active Comparator: Enhanced care control group
This group is designed to be an active control which provides detailed information about substance use, suicide risk, and depression without providing any CBT or other specific therapy.
|
This active control provides detailed information about substance use, suicide risk, and depression to those enrolled.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Level of Suicidal Ideation
Time Frame: Six months
|
Six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
May 20, 2010
First Submitted That Met QC Criteria
May 20, 2010
First Posted (Estimate)
May 21, 2010
Study Record Updates
Last Update Posted (Estimate)
May 13, 2015
Last Update Submitted That Met QC Criteria
May 11, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5R21DA026925-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA); Rush University Medical CenterCompletedSubstance-Related Disorders | Substance Use | Substance AbuseUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentActive, not recruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
Clinical Trials on CBT for suicide in Substance abuse
-
University of MichiganNational Institute on Drug Abuse (NIDA)Completed
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedMood Disorders | Schizophrenia | Substance DependenceUnited States
-
VA Office of Research and DevelopmentCompleted
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
-
VA Eastern Colorado Health Care SystemRecruitingDepression | SuicideUnited States
-
VU University of AmsterdamCompletedSubstance Abuse | Domestic ViolenceNetherlands
-
VU University of AmsterdamUnknownSubstance Abuse | Domestic ViolenceNetherlands
-
University GhentRecruitingSuicidal Ideation | Suicide | Suicide PreventionBelgium
-
University of Massachusetts, WorcesterCompletedSmoking | Drug Abuse | Alcohol AbuseUnited States
-
Boston Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Dependence | Alcoholism | Drug DependenceUnited States